Societe Generale’s AbbVie ABBV Stock Holding History

Societe Generale’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$55.6M	Buy	+898,718	New	+$54.8M	0.4%	31

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Societe Generale's ABBV Position: Q2 2016 in Review

Societe Generale opened a new position in AbbVie (ABBV) in Q2 2016: 898,718 shares worth $55.6M. The stake represents 0.4% of the portfolio and ranks #31 among its holdings.

1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Societe Generale held 898,718 shares of AbbVie worth $55.6M as of Q2 2016.
AbbVie was a new Societe Generale position in Q2 2016.
AbbVie made up 0.4% of Societe Generale's portfolio in Q2 2016, its #31 holding.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.